Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer

PURPOSE: Epigenetic alterations of specific genes have recently been identified as diagnostic biomarkers for human cancers. However, there are currently no standardized epigenetic biomarkers for drug sensitivity in human gastrointestinal cancer. Therefore, the aim of this study is to identify a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Mi-Seong, Song, Sang-Hyun, Yun, Jiyeon, Kang, Jee-Youn, Kim, Hwang-Phill, Han, Sae-Won, Kim, Tae-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843720/
https://www.ncbi.nlm.nih.gov/pubmed/26511811
http://dx.doi.org/10.4143/crt.2015.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843720/
https://www.ncbi.nlm.nih.gov/pubmed/26511811
http://dx.doi.org/10.4143/crt.2015.153

Ejemplares similares